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Abstract
Gcn5-related N-acetyltransferases (GNATs) are
found in all kingdoms of life and catalyze
important acyl transfer reactions in diverse cellular
processes. Although many of their structures
and/or functions are known, a significant number
of GNATs remain functionally and structurally
uncharacterized. Even when the 3D structures of
these proteins have been determined, most do not
contain acceptor substrates bound in their active
sites. The underlying challenge with obtaining 3D
structures of GNATs with functionally relevant
ligands bound in their active sites involves
discerning which ligands are potentially
functionally relevant for a protein of unknown
function, and coaxing the protein to bind and
retain the ligand within the crystal for structure
determination.
To expand upon existing
crystallographic strategies for improving ligand
bound GNAT structures, we have synthesized
peptide substrate analogs and reacted them with
CoA in PA4794 protein crystals to form
bisubstrates. We found two separate mechanisms
for bisubstrate formation: 1) direct alkylation of
CoA with a halogenated peptide, and 2) X-ray
induced radical-mediated alkylation of CoA with
an alkene peptide. Additionally, we present a
computational approach for identifying potential
key residues over the course of the enzymatic
reaction using these structures in complex with
bisubstrates. We term this method product-based
transition-state modeling (PBTSM), as docking
and molecular dynamics simulations of these
interactions occur in the reverse direction, i.e.
from products to substrates. Our approach is
widely applicable across the GNAT superfamily
and can be used to improve the success rate of
obtaining liganded structures of other GNATs,
including histone acetyltransferases.
Introduction
The three-dimensional structures of proteins with
ligands bound in their active sites are valuable
tools because they provide a framework for
determining residues that bind ligands over the
course of an enzymatic reaction.(1) In the present
age where new sequencing information greatly
exceeds the experimental functional annotation of
genes, liganded structures yield important
information that can be used to more accurately

	
  

computationally predict protein function or modes
of ligand binding. Using structural information to
enhance our understanding of acetyltransferases is
critically important, since transferring an acetyl
group from one molecule to another is a
fundamental biochemical process. Members of
the very large Gcn5-related N-acetyltransferase
(GNAT) superfamily are found in all kingdoms of
life and play key roles in metabolic and cellular
processes, including gene regulation, transcription,
post-translational
protein
modification,
detoxification and drug resistance.(2, 3) These
proteins use an activated acyl-donor, typically
acetyl-coenzyme A (AcCoA), to transfer an acyl
group to an acceptor substrate. The identity of the
acceptor substrate can range from small
molecules, such as polyamines, antibiotics, or
arylalkylamines to peptides and proteins.(2, 4, 5)
Although many proteins belonging to this family
have been investigated, many members remain
uncharacterized and would benefit from additional
structural and functional investigation.
GNATs have two adjacent but distinct substratebinding sites: [1] the acyl donor substrate binding
site, and [2] the acceptor substrate binding site.
Hundreds of 3D structures of GNATs have been
determined and deposited into the Protein Data
Bank (PDB). While many of these structures have
AcCoA/CoA bound in the acyl donor substrate
binding site, it is less common to have ligands
bound in the acceptor substrate binding site.
Furthermore, the acyl donor site is highly
conserved,
making
protein-CoA
binding
interactions in a newly-sequenced GNAT easier to
predict. On the other hand, the acceptor substrate
binding site, which is responsible for specificity, is
quite diverse among GNATs and more difficult to
predict ligand binding modes. Obtaining structures
of GNATs with bound acceptor substrates is
therefore crucial for understanding these enzymes.
This has proven to be challenging, for even if the
function of the protein is known or potential
acceptor substrates have been identified the
enzymes often do not bind the ligand in the
crystal. Thus, new approaches and tools are
needed to efficiently yield structures with acceptor
ligands bound so we can more effectively
understand key substrate recognition elements for
catalysis across this diverse family of enzymes.
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One strategy for obtaining liganded structures has
been to crystallize proteins in the presence of
bisubstrate inhibitors.(6, 7) These types of
inhibitors have also been employed in medicinal
chemistry in the design of more potent inhibitors,
notably in the area of acetyltransferases and
kinases to encompass both substrate binding
pockets.(8, 9) The binding affinity of an enzyme
for a bisubstrate can be significantly greater than
that of the substrate alone; therefore, it is expected
the enzyme will more efficiently bind the ligand in
the crystal. Many GNAT structures have been
determined in the presence of bisubstrates where
the bisubstrate molecule is either synthesized by
the enzyme itself or chemically prior to
crystallization.(2, 4, 5, 10-15)
In our previous work, we used a broad-substrate
screening assay as a method to identify acceptor
substrates for an uncharacterized PA4794 GNAT
enzyme from Pseudomonas aeruginosa and then
structurally and kinetically characterized it in the
presence of a dipeptide substrate.(16) We found
that PA4794 acetylates the dipeptide Nphenylacetyl glycine lysine (NPAcGK) and
determined the structure of the ternary complex
with CoA and acetylated NPAcGK (PDB ID:
4L8A) (16). Here, we have used the PA4794
enzyme as a model enzyme from the GNAT
family to develop a streamlined procedure for
increasing liganded crystal structures of GNATs in
the presence of bisubstrates. Our approach was to
synthesize analogs of the PA4794 substrate and
have the enzyme catalyze the formation of the
bisubstrate in the presence of CoA. The
advantages to this approach are: [1] the synthesis
and purification procedures for acceptor ligands as
opposed to full bisubstrates are much simpler, [2]
it reduces the quantity of costly CoA needed for
formation of the bisubstrate, [3] many different
acceptor ligands can be tested using the same
crystals, and [4] this approach can be used
regardless of the size of the substrate to be bound.
This final advantage is important because the
donor and acceptor substrate binding sites of many
GNATs are connected by a narrow tunnel, which
may not allow a fully formed large bisubstrate
analog to thread through their active sites.
Allowing each substrate to enter its respective
binding site separately facilitates formation of a

	
  

bisubstrate even with a large or bulky acceptor
substrate during crystal soaks or co-crystallization.
In this work, we describe two separate threedimensional structures of PA4794 with NPAcGK
analog-derived bisubstrates formed in the active
site through two different mechanisms with CoA.
The first bisubstrate was formed through direct
alkylation with a reactive substrate, and the second
bisubstrate was formed through an X-ray induced
radical-mediated addition to the alkene moiety of
the substrate analog. Additionally, we present a
new approach we refer to as product-bound
transition-state modeling (PBTSM) to simulate the
reaction pathway of PA4794 catalysis in reverse
chronological order beginning with products and
proceeding
through
the
tetrahedral
intermediate/transition state toward substrate
binding to explore key interactions within the
active site along the reaction trajectory. We then
interrogated some of the key active site residues
identified through the bound bisubstrate structures
and PBTSM molecular dynamics analyses by
preparing point mutations and testing enzymatic
activity. The approach outlined herein is widely
applicable across the GNAT superfamily,
especially those that show a preference for lysine
acetylation, and can be used to advance the
knowledge of modes of ligand binding in the
acceptor site. This will ideally lead to more
accurate computational methods of functional
prediction of GNATs and drug design.
Results
Design of substrate analogs—We previously
found that PA4794 acetylates the ε-amino group of
NPAcGK and prefers to acetylate a C-terminal
lysine residue of peptides(16), yet its native
function remains unknown. We chose this enzyme
as a model system for exploring formation of
bisubstrates in GNATs because it is small and
readily crystallizes, which makes it an ideal
protein to study mechanisms of ligand binding. To
begin, we analyzed the 3D structure of the ternary
complex of PA4794 and its interactions with CoA
and acetylated NPAcGK (NPAcGAcK) peptide
(PDB ID: 4L8A) and designed and synthesized
reactive analogs of the acceptor substrate that
would react with CoA to form bisubstrates in the
protein crystal. We reasoned that electrophilic
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moieties installed near the ε-amino group of the
acceptor substrate should be capable of alkylating
the thiol of free CoA to produce a bisubstrate in
the active site of the protein. To mimic the acetyl
group transferred from CoA to the acceptor but
with a reactive moiety, we installed an αhaloacetyl group on the ε-nitrogen of the lysine.
The α-haloacetyl moiety has been utilized
extensively as a group to alkylate active site
residues in proteins(17), and in a similar approach,
Hwang incorporated an α-haloacetyl moiety as a
replacement for the acetyl moiety of AcCoA,
which was able to react with active site residues of
acetyltransferases that use AcCoA(18). Our
approach for synthesizing haloacetyl substrates is
summarized in Scheme 1 and was accomplished
by reacting NPAcGK with chloroacetyl chloride or
bromoacetyl chloride to obtain compounds 2a and
2b, respectively. The PA4794 enzyme-mediated
formation of bisubstrate 3 occurred in the presence
of CoA with these compounds in the active site.
Bisubstrate formation in crystals via an enzymemediated mechanism—We grew crystals of the
PA4794 protein and soaked them with CoA,
followed by soaking with the 2a and 2b
chloroacetyl and bromoacetyl analogs (see
Experimental Procedures for more details) and
screened crystals for ligand binding. We found
both analogs reacted with CoA to form bisubstrate
3 (Scheme 1, Figure 1A) and exhibited identical
binding modes in the structures (Figure 1; PDB
IDs: 5VDB, 5VD6). Although the bromoacetyl
derivative 2b yielded the same bisubstrate as the
chloroacetyl derivative 2a, the resolution of the
structure from bromide 2b was lower, perhaps due
to the greater reactivity of the bromo compound
leading to less selective and more random
reactivity, or simply from greater radiation
damage to the crystal. Hence, only the structure
derived from chloroacetyl derivative 2a was
refined (PDB ID: 5VDB). The bisubstrate was
formed via an enzyme-mediated mechanism
whereby the enzyme active site placed the
electrophilic alkylating moiety in close proximity
for SN2 displacement of the halide by the thiol of
CoA.
Bisubstrate formation in crystals via a radicalmediated mechanism—When we soaked crystals
of PA4794 with CoA and the alcohol/alkene
	
  

mixture (4/5) (Scheme 2), our assumption was that
the alcohol would bind preferentially in the active
site of the enzyme, given the alcohol’s ability to
serve as both H-bond donor and H-bond acceptor,
and the comparable steric volume to the amine
substrate. We were surprised to observe formation
of bisubstrate 6 in the structure (Scheme 2, Figure
1B, PDB ID: 5VD6). This was curious because
both alcohol and alkene were expected to be
chemically unreactive. To determine the
mechanism of bisubstrate formation between the
alcohol/alkene analog and CoA, we performed a
series of tests to determine if it was produced
enzymatically from the alcohol 4 or alkene 5.
Treatment of the 4/5 mixture with the PA4794
enzyme and CoA did not give rise to any
detectable bisubstrate 6 by HPLC. However, it is
well known that a thiol can add to an alkene under
free radical conditions(24), which could have been
initiated during X-ray data collection, so we tested
whether or not the 4/5 mixture could produce a
bisubstrate in the presence of a source of radicals.
Treatment of 4/5 and CoA with AIBN at 65°C for
2 hours showed complete consumption of the
alkene 5 from the mixture and corresponding
reduction in the concentration of CoA (see
Supplemental Figure S16). There was no
detectable effect on the concentration of alcohol 6,
and the production of a new polar peak close in
retention time to CoA was shown to be bisubstrate
6 by mass spectrometry (M¯ observed = 1070.2),
providing strong evidence that the formation of the
bisubstrate 6 was due to a radical-mediated
mechanism from X-ray irradiation during data
collection.
Two distinct substrate analog binding modes
reveal functionally important interactions—The
bisubstrate analogs formed in the present study
through either an enzyme- or radical-mediated
mechanism occupy both the AcCoA and acceptor
substrate binding sites and enable exploration of
key interactions in both pockets. The CoA
moieties of bisubstrates 3 and 6 are bound in
similar conformations and through similar
interactions as those of previously determined
PA4794 structures (PDB IDs: 3PGP, 4KUB,
4L8A, Figure 1). Bisubstrate 6 binding is similar
to that of the acylated substrate observed in the
ternary complex (PDB ID: 4L8A) structure with
NPAcGAcK (Figure 1C). In particular, the most
4	
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critical charge-charge interactions of the Cterminal carboxyl group of NPAcGAcK occur
with R49 and the main chain nitrogen of N80 as
well as several water-mediated interactions. The
phenylacetyl moiety lies against a hydrophobic
patch composed of residues F118, F27 and P31.
The moiety corresponding to the C-terminal lysine
side chain of the bisubstrate 6 (Figure 1B) is
shorter by four atoms and in an extended
conformation compared to the acetylated lysine
side chain of the product NPAcGAcK. The
bisubstrate compound 3 (Figure 1A) exhibits a
different binding mode compared to the acylated
product shown in Figure 1C, but this can be
attributed to the longer-atom chain connecting the
lysine mimetic to CoA. The modified acetyllysine moiety in bisubstrate 3 is extended and is
not as distorted as in the ternary complex
structure. Specifically, this is due to a movement
of the C-terminal carboxyl group of the peptide
that now interacts with more surface exposed
R141 instead of R49 (Figure 1A). R141 is located
closer to the binding pocket opening than R49 and
allows a more extended conformation of the
substrate analog moiety, which is slightly less
buried inside of the protein as compared to
bisubstrate 6 (Figure 1B). In this case, additional
interactions are observed between the ε-amino
group and the acetyl oxygen of the haloacetyl
substrate analog derivative and the main chain
oxygen of S116 and main chain nitrogens of N80
and M81. The two distinct conformations of the
two bisubstrate analog moieties also induce
significantly different conformations of Y68.
Importance of R49 and R141 residues of
PA4794—The binding mode of the two
bisubstrates revealed two arginine residues (R49
and R141) that are implicated as playing a
potentially important role in binding substrate
and/or product. To elucidate whether these two
residues were critical for activity, we constructed
alanine and glutamine mutants and compared their
kinetic activity to the wild-type enzyme. We could
not completely remove the polyhistidine tag from
all mutants; therefore, we screened the kinetic
activity of all mutants and wild-type proteins in
the presence of the tag for this experiment. We
previously determined the R49Q mutant displayed
reduced PA4794 catalytic activity, but included it
here since the tag was not present previously. (16)

	
  

All five mutants (R49A, R49Q, R141A, R141Q,
and R49QR141Q) showed a significant decrease
in activity (between 3.5- and 23-fold decrease)
compared to the wild-type enzyme, with the most
severe decrease seen for the double mutant (Figure
2). Replacing the more surface-exposed arginine
R141 with glutamine (R141Q) exhibited
diminished activity compared to the wild-type
protein, but its replacement with alanine (R141A)
showed a greater decrease in activity (Figure 2).
R49 mutations also led to decreased activity
relative to wild-type, but the glutamine and alanine
mutants showed opposite effects compared to the
R141 mutants: the R49A retained greater activity
relative to R49Q. Regardless, it is clear that both
of these residues are important for binding peptide,
and at least one needs to be present for catalysis to
occur.
Product-Based
Transition-State
Modeling
Approach—To complement our enzyme kinetics
results and elucidate potential roles of residues
during catalysis, we used a new in silico modeling
method we refer to as Product-Based TransitionState Modeling (PBTSM) (See Experimental
Procedures for details) to elucidate hypothetical
substrate and tetrahedral intermediate binding
modes for PA4794. This method proceeds in
reverse chronological reaction order beginning
with reaction products and progressing back
through the tetrahedral intermediate toward the
original substrates. The process is summarized in
Figure 3. Crystallographic data of enzymatic
reaction products (PDB ID: 4L8A) or bisubstrate 3
were used as a starting point to systematically
backtrack through the catalytic intermediate steps
to computationally guide the placement of atoms
that are likely to occur during formation of the
tetrahedral intermediate and substrate binding.
Active site regions important along the reaction
trajectory—Using the bisubstrate bound crystal
structures and the PBTSM protocol, we identified
a set of important regions of the active site that
appear to stabilize the tetrahedral intermediate and
enable the catalytic reaction to proceed. For
instance, we identified a potential oxyanion hole
composed of the backbone amide hydrogen of
M81 near the alpha carbon hydrogen of C29 and
the backbone amide hydrogen of N80 through a
water molecule that could stabilize the negatively
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charged oxygen of the tetrahedral intermediate
(Figure 4A, blue circle). The water observed in the
crystal structure is present at a nearly identical site
as the one observed using the PBTSM protocol,
which suggests it plays an important role in the
acetyl transfer mechanism when the system is
solvated. We also observed that H-bonds were
formed directly through two backbone carbonyl
oxygens of S116 and L78 or indirectly through a
water molecule to stabilize the nucleophilic
approach of the ε-amino group of NPAcGK during
formation of the tetrahedral intermediate (Figure
4A, red circle). Two important arginine residues
stabilize the C-terminal carboxyl group of the
NPAcGK substrate (Figure 4A, black square).
Binding of the carbonyl oxygen atom in the
oxyanion hole allows the accompanying elements
involved in formation of the tetrahedral transition
state intermediate leading to acetyl transfer to be
recognized. A shallow hydrophobic pocket
containing L78, I115, Y128 and M81 residues was
also observed to accommodate the methyl of the
acetyl group. Finally, the model indicates that the
sulfur of CoA forms a stabilizing H-bond
interaction with Y128 and an ordered water
molecule. This catalytic tyrosine has been
predicted to play a role as a general acid capable
of reprotonating CoA after transfer of the acetyl
group to the acceptor substrate has occurred.(16)
The ordered water makes further interactions with
the backbone carbonyl of Y28, while H-bond
donation varies between the backbone amide of
F118 and the side chain amide of N121. The
PBTSM-generated transition state models are
shown in Figures 4B and 4C.
Kinetic mechanism
of PA4794 toward
NPAcGK—GNAT enzymes typically use either a
sequential (direct transfer) mechanism whereby
both donor and acceptor substrates bind to the
enzyme simultaneously and the acetyl group from
AcCoA is transferred directly to the substrate, or
they use a ping-pong or double-displacement
mechanism with an indirect transfer of the acetyl
group via an acetyl-enzyme intermediate. In the
latter mechanism, AcCoA binds first and transfers
the acetyl group to a residue in the enzyme active
site and then CoA leaves. Then the acceptor
substrate binds and the acetyl group is transferred
from the enzyme to the acceptor substrate. Since
our PBTSM modeling experiments predicted a

	
  

tetrahedral transition-state intermediate, which is
indicative of a direct transfer mechanism, we
performed enzyme kinetic assays and tested
kinetic models to experimentally determine which
kinetic mechanism was preferred for PA4794.
Similar to other GNATs, we found the PA4794
protein indeed uses a bisubstrate steady-state
kinetic mechanism(25, 26) (see Supplemental
Materials Fig. S1), which infers an overall direct
transfer of the acetyl group to the acceptor
substrate through a transition state intermediate.
Thus, our in vitro and in silico results are
compatible.
Mechanistic hypothesis of overall PA4794
reaction sequence—Based on our combined in
vitro and in silico results, we propose the sequence
of substrate approach, acetyl transfer and final
product release in PA4794 occurs as follows. Our
kinetic mechanism results indicate there is no
specific order of binding of AcCoA and NPAcGK,
thus both substrates may approach the active site
in a random order. When the NPAcGK substrate
binds, its C-terminal carboxylate interacts with
R141 (located near the binding pocket opening) or
R49 (located closer to the catalytic center), and the
lysine moiety approaches the catalytic site as a
neutral species, having been deprotonated by bulk
solvent or an unidentified basic residue near the
active site. (16) The nucleophilic ε-amino group of
NPAcGK is guided into the correct conformation
by residues that stabilize the incipient positive
ammonium species while the acetyl oxygen takes
its place in the oxyanion hole. Immediately
following
formation
of
the
tetrahedral
intermediate, the bond between the carbonyl
carbon and the sulfur breaks while the negative
charge on sulfur is stabilized and ultimately
protonated by Y128. Reprotonation of Y128 may
come from bulk solvent or from deprotonation of
the positively charged ammonium species. The
acetylated NPAcGAcK product and CoA would
then exit the active site and the catalytic cycle
continues. Our mechanistic hypothesis for acetyl
transfer by PA4794 is summarized in Figure 5.
Discussion
We have designed two distinct types of tools that
utilize different mechanisms to form bound
bisubstrates in GNAT protein crystals: [1]
chloroacetyl/bromoacetyl derivatives of an
6	
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acceptor substrate using an enzyme-mediated
mechanism and [2] addition of a thiol to an alkene
derivative of acceptor substrate via a radicalmediated mechanism. We chose to use the
PA4794 protein of unknown native function from
P. aeruginosa as a model system to test our
bisubstrate tools since its crystallization is highly
reproducible, with fast growth of crystals that
typically give high-resolution structural data.
Upon soaking crystals of PA4794 with the
chloroacetyl derivative of NPAcGK 2a in the
presence of CoA followed by structure
determination, we observed that the protein
enzymatically formed a covalent bisubstrate
(Figure 1) occupying both AcCoA and acceptor
substrate sites. Incubation of PA4794 crystal with
bromoacetyl substrate 2b yielded an identical
bisubstrate-bound complex but of lower
resolution.
The formation of bisubstrate 6 was unexpected,
but can be attributed to radiation-induced freeradical-mediated addition of the thiol to the alkene
moiety of 5. We hypothesize that bisubstrate 6 was
not produced enzymatically, but rather through
exposure to free radicals produced by X-ray
irradiation during data collection (Scheme 3). XRay induced chemical modification of specific
moieties is well documented, and sulfurcontaining
residues
are
particularly
susceptible.(27) Scheme 3 presents a mechanistic
hypothesis for the formation of bisubstrate 6 in the
active site mediated by hydroxyl radicals produced
from the interaction of radiation with ubiquitous
water molecules in and around the active site. Hatom abstraction from CoA by a hydroxyl radical
would yield the thiol radical, which could rapidly
add to the carbon-carbon double bond of alkene 5
yielding a secondary radical. This radical could
then abstract a hydrogen atom from water or a
nearby residue to obtain bisubstrate 6. The same
overall mechanism is expected in the AIBNmediated process with H-atom abstraction from
CoA by the isobutyronitrile radical produced from
thermal loss of nitrogen from AIBN. The radicalmediated addition of the thiol moiety of CoA has
not been previously employed to prepare Salkylated derivatives of CoA, and as demonstrated,
this method may be used to prepare bisubstrates of
acyltransfer enzymes that employ CoA. There are
several reports of the conjugate Michael addition

	
  

of the thiol moiety of CoA to enones(28-30) but
1,4-addition requires an activating group, typically
a carbonyl.
The results of the enzyme-mediated and radicalmediated bisubstrates combined with PBTSM and
enzyme kinetics studies provide new information
regarding key residues that are important for
PA4794 substrate binding and tetrahedral
intermediate stabilization. The two different
binding modes of the bisubstrates showed two
arginine residues can interact with the carboxylate
of the NPAcGK substrate: R49 and R141. The
alkyl side chain of the C-terminal lysine of the
substrate is less distorted in the bisubstrate 3 and
bisubstrate 6 structures compared to the ternary
complex (PDB ID: 4L8A) structure. The
carboxylate of bisubstrate 3 interacts with R141
instead of R49 because the bisubstrate is formed
by sulfur attacking the alpha-CH2 of the
chloroacetyl group, which provides an extra
methylene and lengthens the molecule versus the
sulfur attacking the e-carbon of the alkene for
formation of bisubstrate 6. In absence of the
complex structure with bisubstrate 3, we would
not have identified R141 as a potentially important
residue for ligand binding. It appears that either
arginine residue can contribute to ligand
stabilization for catalysis, but turnover is
dramatically decreased when both are not present.
Since the native substrate of this enzyme is not yet
known, these results provide new information
about the architecture of the active site that is
critical for catalysis.

Our study has expanded upon the tools for forming
bisubstrates for GNAT structure determination and
can be applied to other acyltransferases, which
indicates their broad applicability across enzyme
families and types of acceptor substrates. In
particular, our serendipitous radical-mediated
approach for producing bisubstrates could enhance
the quantity of acyltransferase crystal structures or
other enzymes that use CoA obtained in complex
with specific ligands through employment of
unactivated alkene derivatives. Since PA4794 is
specific for acylating a C-terminal lysine residue,
we consider it a model system for identifying the
best chemical approaches for studying and
designing specific inhibitors for other lysine
7	
  

GNAT catalyzed and radical-mediated bisubstrates	
  

	
  
	
  
acetyltransferases,
such
as
histone
acetyltransferases. Furthermore, substrates armed
with alkylating agents can serve as covalent
inhibitors with therapeutic application, especially
given the recent (re)acceptance of covalent
inhibitors as drugs(31) including those targeting
protein kinases.(32)Finally, our PBTSM approach
for modeling the mechanism of an enzyme in
reverse chronological order offers a new approach
to utilizing product- or bisubstrate-bound
structures in predicting key enzyme interactions
involved in catalysis, and in identifying specific
amino acid residues for further study.
Experimental Procedures
Materials - All solvents were distilled prior to use,
and all reagents were used without further
purification unless otherwise noted. All synthetic
reactions were conducted under a nitrogen
atmosphere. Silica gel 60A, 40−75 µm (200 × 400
mesh), was used for column chromatography.
Aluminum-backed silica gel 200 µm plates were
used for TLC. 1H NMR spectra were obtained
using either a 300 MHz spectrometer or a 500
MHz spectrometer with trimethylsilane (TMS) as
the internal standard. 13C NMR spectra were
obtained using a 75 MHz spectrometer or a 125
MHz spectrometer. HRMS spectra were measured
on a TOF instrument by electrospray ionization
(ESI).
Acetyl coenzyme A (AcCoA) and
coenzyme A (CoA) trilithium salts and Nphenylacetylglycine lysine (NPAcGK) were
purchased from Sigma-Aldrich. All other reagents
for biochemical assays were purchased at the
highest quality available.
Synthesis of compounds to form bisubstrates —
NPAcGK (1) was reacted with chloroacetyl
chloride, and also with bromoacetyl bromide,
affording electrophilic derivatives 2a and 2b,
respectively (Scheme 1). As detailed below, 2a
and 2b both yielded the same bisubstrate 3 in the
active site of PA4794. We employed a classic
nitrous acid conversion of the primary ε-amine of
the lysine moiety of NPAcGK to obtain a mixture
of the alcohol 4 and alkene 5, produced by
reaction with water, or by elimination, respectively
(Scheme 2).
We found that the diazonium
reaction utilizing sodium nitroprusside(23) was
milder and higher yielding than the traditional
	
  

sodium nitrite and hydrochloric acid. The mixture
of 4 and 5 proved to be inseparable with normalphase chromatography, nevertheless this provided
the mixture to test as a potential substrate for the
enzyme, as well as providing material for
cocrystallization.
Synthesis
of
N6-(2-chloroacetyl)-N2-((2phenylacetyl)glycyl)-L-lysine (2a)— K2CO3 (46.0
mg, 0.33 mmol) was added to a solution of
NPAcGK 1 (53.0 mg, 0.165 mmol) in deionized
water (0.55 mL). The reaction mixture was then
cooled in an ice bath and chloroacetyl chloride
(19.8 µL, 28.0 mg, 0.248 mmol) was added under
nitrogen slowly over several minutes via micro
syringe, and the reaction was allowed to warm to
RT over 4 hours. The pH of the reaction was
adjusted to 4 by adding 4N HCl before
liquid/liquid extraction with three portions of
ethylacetate to recover the desired product. The
combined organic fractions were washed with
brine and dried over magnesium sulfate before
being concentrated under reduced pressure to
afford the desired chloroacetyl derivative 2a as a
colorless glass (34.3 mg, 52%): 1H NMR (500
MHz, 1:3 CDCl3 + d6-DMSO) δ 12.7 (bs, 1H),
7.91 (t, J=5.5 Hz, 1H), 7.78 (t, J= 5.0, 1H), 7.65
(d, J=8 Hz, 1H), 7.32-7.21 (m, 5H), 4.37 (dt,
J=8.5, 5 Hz, 1H), 3.96 (s, 2H), 3.86 (d, J=5.5 Hz,
2H), 3.56 (d, J=2 Hz, 2H), 3.16 (q, J=6.5 Hz, 2H),
1.84-1.77 (m, 1H), 1.62 (m, 1H), 1.47 (n, J=7 Hz,
2H), 1.32 (m, 2H); HRMS (MH)+ calc for
C18H25ClN3O5, 398.1483; found, 398.1477.
Synthesis
of
N6-(2-bromoacetyl)-N2-((2phenylacetyl)glycyl)-L-lysine (2b)— In a manner
analagous to 2a, bromoacetyl derivative 2b was
prepared as a colorless glass (34 mg, 16%): 1H
NMR (500 MHz, d6-DMSO) δ 13.03 (bs, 1H),
8.27-8.23 (m, 2H), 8.08 (d, J=8Hz, 1H), 7.31-7.19
(m, 5H), 4.17 (dt, J=8.5, 5Hz, 1H), 3.81 (s, 2H),
3.76 (dd, J=29, 5.5Hz, 1H), 3.73 (dd, J=29, 6Hz,
1H), 3.48 (s, 2H), 3.04 (q, J=6Hz, 2H), 1.69 (m,
1H), 1.56 (m, 1H), 1.41-1.24 (m, 4H).
Synthesis
of
(S)-6-hydroxy-2-(2-(2phenylacetamido)acetamido)hexanoic acid (4)
and (S)-2-(2-(2-phenylacetamido)acetamido)hex5-enoic acid (5). NPAcGK (1) (100 mg, 0.312
mmol) was dissolved in nano-pure H2O (4mL)
followed by 4N NaOH (60 µL). The mixture was
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then heated overnight at 60°C.
Sodium
nitroprusside (115.1 mg, 0.386 mmol) was added
to a separate vial and dissolved in H2O (200 µL)
with gentle heating. The nitroprusside was then
added to the NPAcGK basic solution slowly with
alternating 30 µL portions of nitroprusside
followed by 30µL of 4N NaOH over 35 min, total
volume equaling 150 uL of iron catalyst solution
and 170 uL NaOH. The sample was then allowed
to stir at 60°C overnight. The reaction was
adjusted to pH 4 by adding 4N HCl before
liquid/liquid extraction with three portions of ethyl
acetate to recover the desired product. The
combined organic fractions were washed with
brine and dried over magnesium sulfate before
being concentrated under reduced pressure to
afford the desired alkene/alcohol product mixture
4/5 as a colorless oil (30.1 mg, 30%). RP LC-MS
analysis on a Surveyor Liquid Chromatography
system equipped with a Symmetry Shield RP18
column (5.0 µm, 100 Ǻ) and coupled to an LCQ
Advantage Mass Spectrum System (Elution with a
5 % CH3CN (0.1 v/v TFA)-H2O [A]/ 100 %
CH3CN (0.1 v/v TFA) [B] at 1mL/min flow rate
and Ttotal = 20 min. Solvent gradient of T0 min = 90
% A / 10 % B to T15 min = 10 % A / 90 % B until
gradient switch at T15.1 min back to 90 % A / 10 % B
until T20 min) was performed. The alcohol 4
retention time was 5.067 min (MS m/z calc for
C16H22N2O5 obs 322 and alkene 5 retention time
was 7.414 min (MS m/z calc for C16H20N2O4 304,
obs 304). The product mixture was used without
further purification.
Clones and site-directed mutagenesis—The
PA4794 gene was cloned into the ampicillin
resistant p11 pET-derived vector as described
previously(16). Site-directed mutagenesis was
performed using the Phusion site-directed
mutagenesis kit from Thermo Fisher Scientific,
PA4794 WT template DNA, and 5’phosphorylated primers to create R49A, R49Q,
R141A, R141Q, and R49QR141Q mutants.
Primers
included:
R49A
forward
atcgccgaagcacgcggcagc,
R49Q
forward
atcgccgaacagcgcggca,
R49
reverse
ggcggcggccagctggg,
R141A
forward
atcgccgaagcgcacgatccg,
R141Q
forward
atcgccgaacagcacgatccg, and R141 reverse
ggcgcgcggctggtagcc. Mutations are underlined.
The R49QR141Q mutant was constructed using

	
  

R49Q DNA as template and primers for R141Q.
See Supplemental Tables S1 and S2 for details of
mutagenesis conditions. After PCR, the products
were ligated as described in the kit, transformed
into E. coli DH5alpha competent cells prepared
using the Zymo Mix & Go transformation kit, and
plated on LB-Agar plates containing 100 µg/mL
ampicillin. Bacterial colonies were submitted to
Genewiz for DNA sequence confirmation.
Afterwards, colonies containing plasmids with
correct sequences were grown and DNA was
purified and transformed into BL21(DE3)
competent cells prepared using the Zymo Mix &
Go transformation kit for protein expression.
Protein expression and purification—The WT
PA4794 protein for crystallization was expressed
and purified as described previously(16). All WT
and mutant plasmids for kinetic studies were
transformed into BL21(DE3) cells and grown in
100 mL of terrific broth (TB) in 500 mL shaker
flasks on a benchtop shaker at 37°C until the
OD600nm reached 0.6-0.8. Cultures were chilled on
ice and then 0.5 mM IPTG was added to induce
protein expression overnight at RT on a benchtop
shaker. The next day cells were harvested by
centrifugation, resuspended in 15 mL of lysis
buffer (10 mM Tris-HCl pH 8.3, 500 mM NaCl,
5% glycerol, 5 mM beta-mercaptoethanol (BME),
and 5 mM imidazole), sonicated, and centrifuged.
The supernatant (crude extract) was loaded onto a
1 mL Hi-Trap FF Ni-affinity column (GE
Healthcare) equilibrated with buffer A (10 mM
Tris-HCl pH 8.3, 500 mM NaCl, 5 mM BME)
using an AKTA Start FPLC system (GE
Healthcare) at a flow rate of 1 mL/min. Unbound
sample was washed from the column (5 CVs of
buffer A plus 25 mM imidazole) and purified
protein was eluted from the column with buffer B
(5 CVs of buffer A plus 500 mM imidazole).
Proteins were desalted using a PD-10 column (GE
Healthcare) by gravity flow into buffer A and
concentrated to <0.5 mL using Sartorius 6 mL
concentrators with 10K MWCO. The polyhistidine
tag on the WT protein was cleaved using TEV
protease (purified as described previously(16)) in a
20:1 ratio of purified protein to TEV protease in
Slide-a-lyzer dialysis tubes (Thermo Fisher
Scientific). The cleavage buffer (50 mM Tris-HCl
pH 8.3, 300 mM NaCl, 5% glycerol, 1 mM DTT)
was added to the bottom portion of the dialysis
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tube and incubated at 37°C on an oscillating
shaker for 2 hrs. The buffer in the bottom of the
dialysis tube was discarded, fresh cleavage buffer
was added to the tube, and the sample was at
incubated at 4°C on an oscillating shaker in a cold
cabinet overnight. The sample was centrifuged to
remove any precipitate and the soluble fraction
was loaded onto a 1 mL HiTrap FF column (GE
Healthcare). Protein was desalted using a PD-10
column into buffer A and concentrated as
described above and stored in aliquots at -80°C.
All proteins were purified to near homogeneity as
assessed by SDS-PAGE. We typically remove the
polyhistidine tag from this protein prior to
performing enzyme kinetics because it binds the
tag in its active site (33); however, the efficiency
of TEV cleavage was not consistent for all mutants
and we could not separate the cleaved from noncleaved proteins. Therefore, we prepared a set of
proteins, including all mutant and WT, with the
tag remaining for kinetic analyses in order to
compare all proteins consistently.
Colorimetric Ellman’s enzyme assays—Kinetic
characterization of WT and mutant proteins:
Substrate saturation curves of NPAcGK for the
WT and mutant enzymes were performed using
the Ellman’s colorimetric assay and analyzed as
described previously(16, 34) with the following
modifications. Since the polyhistidine tag could
not be completely removed for all mutants, we
decided to compare the kinetics of all proteins
used for the kinetic analysis with the tags
remaining at their N-termini for consistency. The
enzyme concentration for WT, R49A, R49Q,
R141A, R141Q, or R49QR141Q in the enzyme
assay was 2.5 (WT) and 11.2 µM (all mutants).
Determination of kinetic mechanism: The most
compatible model for the WT PA4794 kinetic
mechanism was determined as described
previously(25) where a series of four NPAcGK
substrate saturation curves at set concentrations of
AcCoA (0.1, 0.25, 0.5, 1 mM) were produced
using cleaved 2.1 µM WT protein while varying
NPAcGK concentrations from 0-25mM. Substrate
analog test: To determine if the PA4794 enzyme
could acetylate the NPAcGK alcohol analog, we
performed the following assay using the 4/5
mixture since the two compounds could not be
separated from each other. A 50 mM stock of the
4/5 mixture was prepared by dissolving the

	
  

compounds in 50 mM Bicine pH 9.0 buffer.
Substrate saturation curves were produced in
triplicate using reactions (50 µL volume)
containing 50 mM Bicine pH 9.0 buffer, 0.5 mM
AcCoA, and varying concentrations of the
alcohol/alkene mixture (from 0-25 mM). The
reactions were initiated with 5.1 µM WT cleaved
enzyme and were processed as described
previously(16). Enzyme-mediated formation of
bisubstrate with alkene: To determine if the
bisubstrate formation was enzyme-mediated, we
prepared a 25 mM stock solution of the 4/5
mixture in 50 mM Bicine pH 9.0. Reactions (50
µL) contained 50 mM Bicine pH 9.0, 5 mM CoA,
and 10 mM 4/5 mixture, and were initiated using
either 1.1 or 11 µM cleaved WT enzyme and
incubated at RT for 19 hrs. Control reactions
included: 1) no enzyme, 2) no enzyme and no 4/5
mixture, 3) and no enzyme, no 4/5 mixture, and
no CoA. The next day 150 µL of MeOH was
added to each sample, centrifuged for 5 min at
21,000 x g, and transferred to an HPLC vial for
analysis. No precipitate was observed.
HPLC analysis of enzyme-mediated formation of
bisubstrate with alkene: To analyze possible
PA4794 enzyme-mediated formation of the
bisubstrate,
high-performance
liquid
chromatography (HPLC) analysis was performed
according to a previously described HPLC
method(35) with the following modifications.
Samples were analyzed on a Hewlett Packard
1050 series HPLC system with diode array
detector (DAD) set to monitor 205 nm using a
Regis Little Champ II ODS guard column coupled
to a SymmetryShield RP18, 3.3 µm, 100A column.
Filtered samples were loaded into standard size
VWR autosampler HPLC vials fitted with 300µL
conical glass inserts. Samples were eluted with a
5% acetonitrile (0.1% v/v TFA)-H2O [A]/ 5%
acetonitrile (0.1% v/v TFA) [B] at 1 mL/min flow
rate. A solvent gradient from 90% A / 10% B at
time 0 to 10% A / 90% B at time 15 min was used.
At time 15.1 min the gradient was switched to
90% A / 10% B for a re-equilibration period until
the end of the method at time 25 min. Samples
were additionally analyzed on a Surveyor Liquid
Chromatography system equipped with a
SymmetryShield RP18, 5.0 µm, 100A column and
a UV-Vis unit set to monitor absorbance between
200-275 nm. The LC system was coupled to an
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LCQ Advantage Mass Spectrometer System
monitoring both positive and negative modes
under full scan.
HPLC analysis of radical-mediated AIBN
formation of bisubstrate with alkene: The radicalmediated AIBN reaction was used to test for
formation of the bisubstrate with the 4/5 mixture
in the presence of coenzyme A. A sample of the
4/5 mixture (2.2 mg, ~6.8 µmol) was dissolved in
HPLC grade methanol (35 µl) followed by
addition of AIBN (300 mg, 0.34 µmol) and CoA
(5.3 mg, 6.8 µmol). The reaction was stirred at
60°C over four hours and then diluted with 2.0 mL
of methanol. HPLC analysis was performed as
described above.
AIBN mediated bisubstrate sample purification
& LC MS/MS analysis: Solid-phase extraction
(SPE) was performed using an AASP Vac-Elut
Model AI 6000 vacuum manifold from
Analytichem International and was regulated to
maintain a flowrate of 3-5 mL/min. The desalting
procedure was performed using a 200 mg Oasis
HLB resin (Waters) extraction cartridge loaded
with a 3 mg sample of concentrated bisubstrate as
follows: The SPE cartridge was conditioned with 1
mL acetonitrile followed by 1 mL of 0.1M
triethylammonium acetate buffer (TEAA) at pH 7.
The crude sample was dissolved in 500 µL 0.1 M
TEAA and loaded onto the SPE cartridge. The
cartridge was washed with 2 x 5 mL of 0.1 M
TEAA followed by 5 mL DI H2O to remove salts
from the sample. The sample was recovered using
three consecutive 500 µL elutions of 70%
acetonitrile-H2O. The purified analyte was then
analyzed with direct inject mass spectroscopy on a
LCQ Advantage Mass Spectrometer System
monitoring negative mode under full scan. Mass
calc for C37H56N9O20P3S 1071.26, found 1070.21.
A MS2 fragmentation ion spectrum was also
obtained for the ion peak at 1070 with a 30%
fragmentation power.(36)
Protein Crystallization—PA4794 protein crystals
were grown using vapor diffusion and hanging
drop setups. The crystallization drops were a 1 µl :
1 µl mixture of protein solution at 9 mg/mL and
the precipitant composed of 2M ammonium
sulfate and 100 mM Bis-Tris pH 6.5. To obtain
structures of the PA4794 protein in the presence of
bisubstrates, apo-form crystals were soaked first
	
  

with 5mM CoA, followed by adding 10mM of the
N6-(2-chloroacetyl)-N2-((2-phenylacetyl)glycyl)L-lysine 2a or mixture of (S)-6-hydroxy-2-(2-(2phenylacetamido)acetamido)hexanoic acid (4) and
(S)-2-(2-(2-phenylacetamido)acetamido)hex-5enoic acid (5). Prior to data collection, each crystal
was transferred to a solution containing a 2:1
mixture of precipitant solution and ethylene glycol
and immediately cryo-cooled in liquid nitrogen.
Tracking and analysis of the experiments were
performed with the LabDB(37) and XtalDB(38)
data management system.
Data collection, structure determination and
refinement—Data collection was performed at the
21-ID-G beam line of the Life Sciences
Collaborative Access Team at the Advanced
Photon Source (APS). Data were collected at a
temperature of 100 K and processed with HKL2000(39). The PA4794 structure (PDB ID: 4L8A)
was used as a model to solve the structure of
PA4794 in complex with bisubstrates by
molecular replacement (MR) using HKL-3000
(40) coupled with MOLREP(41). Refinement was
performed using HKL-3000 coupled with
REFMAC5(42), COOT(43, 44) and selected
programs from the CCP4 package (Collaborative
Computional Project, 1994). The atom B-factors
were refined using anisotropic refinement.
Structure validation was performed using
MOLPROBITY(45) and ADIT(46). Structures of
PA4794 in complex with two bisubstrates were
determined: (A) (3R,20S)-1-(((((((2R,3S,4R,5R)5-(6-amino-9H-purin-9-yl)-4-hydroxy-3(phosphonooxy)tetrahydrofuran-2yl)methoxy)(hydroxy)phosphoryl)oxy)(hydroxy)p
hosphoryl)oxy)-3-hydroxy-2,2-dimethyl-4,8,14trioxo-20-(2-(2-phenylacetamido)acetamido)-12thia-5,9,15-triazahenicosan-21-oic acid (3) and (B)
(2R)-5-((2-(3-((2R)-4-(((((((2R,3S,4R,5R)-5-(6amino-9H-purin-9-yl)-4-hydroxy-3(phosphonooxy)tetrahydrofuran-2yl)methoxy)(hydroxy)phosphoryl)oxy)(hydroxy)p
hosphoryl)oxy)-2-hydroxy-3,3dimethylbutanamido)propanamido)ethyl)thio)-2(2-(2-phenylacetamido)acetamido)pentanoic acid
(6). The coordinates, structure factors, and
intensities were deposited in the PDB (PDB IDs:
5VD6,
5VDB).
Statistics
describing
crystallographic data collection and refinement are
summarized in Table 1.
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In-Silico Modeling—Modeling and molecular
dynamics simulations were performed using
Chemical Computing Group’s MOE (Molecular
Operating Environment).[ Molecular Operating
Environment (MOE), 2013.08;] (47) To
understand the critical components of the PA4794
acetyl transfer reaction mechanism, the crystal
structure of the PA4794 ternary complex (PDB
ID: 4L8A) and the bisubstrate co-crystal structure
obtained from soaking chloroacetyl derivative 2a
and CoA (PDB ID: 5VDB, Figure 1A) were used
to model the tetrahedral intermediate expected to
be generated during the acetyl transfer reaction of
AcCoA (donor) and NPAcGK (acceptor). Two
separate models were prepared as starting points
using MOE’s utility Structure-Prep. (47) First, the
products of the enzymatic reaction were modeled
based on the conformation of bisubstrate 3 in
5VDB using MOE’s utility 3D Builder by first
removing the bond between the bisubstrate sulfur
of CoA and the acetyl methyl carbon of
NPAcGAcK. This left NPAcGK-εNHAc and
HSCoA ligands bound to the active site of the
model. The 4L8A structure(16) already possessed
these two products so no remodeling of the second
model was necessary. Next, the models were
solvated in a simple water box at pH of 7.4 and
treated with NaCl counter ions. Periodic boundary
conditions were enabled, and the hydrogen
bonding network of the model was optimized by
automatic sampling of different tautomer/protomer
states using Protonate3D(48). Atoms were then
optimized with a short, localized molecular
minimization (MM) using the MOE utility
QuickPrep with receptor atom tether constraint
strength set to 10 and atoms further then 8 Å from
the ligand fixed. Refinement proceeded until a
RMS Gradient of 0.1 kcal/mol/Å was reached.
Molecular Dynamics parameters were set to
globally minimize the protein, ligand and solvent
atoms of the models. To minimize variables during
in the simulation, the atoms involved in H-bonding
between the beta-alanine to beta-cysteamine amide
bond were tethered to maintain the occupancy of
the CoA in the active site during the annealing
process. Simulated annealing was then performed
on the product bound models. Molecular dynamics
experiments were performed using a NPA
algorithm with a Amber12:EHT force field, an
initial warming from 0-311 K over 100 ps with
equilibration at 311 K over 100 ps, and a 200 ps
	
  

production stage at constant temperature followed
by a 100 ps cooling stage from 300-0 K.
The two equilibrated and optimized NPAcGKεNAc + HS-CoA product models were then
remodeled to produce tetrahedral intermediate
models. Another local minimization using
QuickPrep was performed to correct the distorted
atomic bonds resulting from manual ligand
modification. Molecular dynamics simulations
were performed to optimize the residue
interactions responsible for stabilizing the
tetrahedral intermediate. A second simulated
annealing simulation was performed as described
above except a 700 ps production stage at constant
temperature followed by a 100 ps cooling stage
from 300-0 K was used. Binding affinities for the
molecular dynamics results were calculated based
on tetrahedral intermediates (Figure 6). Similar
modeling was performed using the MOE 3D Build
utility to systematically transform the tetrahedral
intermediates for each model into corresponding
substrate NPAcGK + AcCoA models. The bond
between N6 and the carbon of the acetyl was
deleted and the double bond of the carbonyl was
reestablished, and the carbonyl oxygen and the
nitrogen atoms were given a neutral charge. Then,
a third and final molecular dynamics simulation
was performed to validate the model using the
same parameters as described above except with a
200 ps equilibration stage and 700 ps production
stage at constant temperature and a 100 ps cooling
stage from 300-0 K. A short molecular mechanic
minimization was performed and binding affinities
were calculated (Figure 8). The differences in
binding modes between the two respective models
for products, tetrahedral intermediates and
substrates were compared to determine the likely
residues critical for acetyl transfer and the most
reasonable substrate approach to the active site.
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TABLE 1. Crystallographic data collection and refinement statistics. * Highest resolution shell
values are shown in parentheses. ** 5% of reflections were randomly assigned to the Rfree set.
Complex

bisubstrate analog 3

bisubstrate analog 6

PDB code

5VDB

5VD6

P21212

P21212

a, b, c (Å)

57.3, 76.1, 39.2

57.1, 76.2, 39.0

α, β, γ (°)

90.0, 90.0, 90.0

90.0, 90.0, 90.0

Resolution (Å)*

1.40 (1.40 - 1.42)

1.20 (1.20 - 1.22)

Observed reflections

237096

325622

Rmerge

0.053 (0.800)

0.067 (0.664)

<I>/<σ(I)>*

39.9 (2.0)

41.3 (2.2)

Completeness (%)*

99.9 (100.0)

99.0 (97.8)

Redundancy*

6.9 (6.8)

6.1 (5.5)

14.5 / 17.0

13.2 / 16.3

Protein

1279

1302

Ligand/Ion

131

100

Water

188

253

Wilson B factor (Å2)

17.7

13.6

Protein (Å2)

19

16

Ligand/Ion (Å2)

29

26

Water (Å2)

36

32

bond length (Å)

0.01

0.01

bond angles (°)

1.2

1.5

99.4

98.1

Data collection
Space group
Unit cell

Refinement
Rwork (%)/Rfree (%)**
No. atoms

B factors

Structure quality
R.m.s. deviations

Statistics
Ramachandran Favored (%)
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FIGURES

Scheme 1. Synthesis of a-haloacetyl derivatives of NPAcGK 2a (X = Cl) and 2b (X = Br) and enzymemediated formation of bisubstrate 3.

Scheme 2. Formation of the alcohol/alkene mixture (4 and 5) from NPAcGK, and radical-mediated
reaction of CoA with alkene 5 to form the covalent bisubstrate 6.
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Scheme 3. Mechanistic hypothesis for the formation of bisubstrate 6 from CoA and alkene 5.
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Figure 1. Comparison of binding products and bisubstrate 3 and 6 analogs. PA4794 is shown as a
gray ribbon diagram. Residues 19-37 are not shown for clarity. (A) PA4794 in complex with bisubstrate
analog 3 synthesized from CoA and chloroacetyl derivative 2a determined at 1.4 Å resolution. (B)
PA4794 in complex with bisubstrate analog 6 synthesized from CoA and alcohol/alkene mixture 4/5
determined at 1.2 Å resolution. (C) Ternary complex structure of PA4794 with the bound reaction
products CoA and N6-acetylated NPAcGAcK. (D) 2Fo-Fc electron density map of the bound bisubstrate
analog 3 (σ=1.0). (E) 2Fo-Fc electron density map of the bound bisubstrate analog 6 (σ=1.0).
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Figure 2. Substrate saturation curves for wild-type and R49 and R141 mutants. Steady-state
enzyme kinetic experiments were performed by holding AcCoA concentration constant at 0.5 mM and
varying NPAcGK peptide concentration. Standard deviations for triplicate reactions for all proteins are
shown. See Experimental procedures for more details.
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Figure 3. Product-Based Transition-State Modeling (PBTSM). Protocol for systematic remodeling of
tetrahedral intermediate and substrate binding modes from product or bisubstrate bound crystal structures.
Molecular minimization (MM) and molecular dynamics (MD) stages in the protocol are shown. Further
details are presented in Experimental Procedures.
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Figure 4. Product-Based Transition-State Modeling (PBTSM) Analysis. A) Schematic diagram of
tetrahedral transition state intermediate indicating important regions of substrate-enzyme interactions in
the active site, including interactions that anchor the substrate C-terminal carboxylate (black square), the
oxyanion hole (blue circle), and stabilizing interactions for substrate amine approach (red circle). B)
PBTSM-generated transition state model based on PA4794 co-crystal structure with products bound
(PDB ID: 4L8A) shown in light green. C) PBTSM-generated transition state model based on PA4794
structure in complex with bisubstrate 3 shown in cyan. The CoA moiety of the tetrahedral intermediate is
shown in dark green and protein side chains are in orange. Amino groups are in dark blue, oxygens in red,
sulfurs in yellow, and waters as red and white spheres.

	
  

24	
  

GNAT catalyzed and radical-mediated bisubstrates	
  

	
  
	
  

O

N80 O
N
H
H O
H

N
H

M81

O

H S
O
CoA
Y128
H
N

O
HN

H

H
N
H

O

O
S116

H
N

H
O

CH3
H

C
N

R49/R141
NH

N
H

H
O

H

O

H
N
L78

Substrate + AcCoA

R49/R141
NH

H C
M81
O
N
H H
N80 O N
HN
O
N
H H
H O
B
H O CH3
O
H
O
S
N
CoA
H H
Y128
H
H
N O O O N
H H
S116
L78

Transition State Intermediate

O

N
H

N80 O
N
H
H O
H
CoA

O

SH
H
N

M81

O
HN

H

H
N
H

O

C
N

R49/R141
NH
H

CH3
H
O

S116

N
H

O

H

O

H
N
L78

Ac-Product + CoA

Figure 5. Proposed chemical mechanism for PA4794 acetyltransfer. Residues that occupy the
oxyanion hole are in blue, AcCoA substrate is in green, Y128 that acts as the general acid is in brown,
residues that stabilize the epsilon amino group are in red, and NPAcGK peptide with stabilizing arginine
residues in black.

	
  

25	
  

Supplemental Information
Generating enzyme and radical-mediated bisubstrates as tools for investigating Gcn5related N-acetyltransferases
Cory Reidl, Karolina A Majorek, Joseph Dang, Kristen Jew, David Tran, Melissa Law, Yasmine
Payne, Wladek Minor, Daniel P. Becker, and Misty L. Kuhn
Item

Description

Page

Table S1 PA4794 Mutagenesis Conditions

2

Table S2 Phusion Site Directed Mutagenesis Thermocycler conditions

3

Fig. S1

4

Fig. S2

Series of NPAcGK curves at varying concentrations of AcCoA to
determine kinetic mechanism.
1
H NMR spectrum of chloroacetyl PhAcGK 2a

Fig. S3

Homonuclear 1H-1H COSY NMR of chloroacetyl PhAcGK 2a

6

Fig. S4

Mass spectrum of chloroacetyl PhAcGK 2a

7

Fig. S5

1

8

Fig. S6

13

Fig. S7

Homonuclear 1H-1H COSY NMR of bromoacetyl PhAcGK 2b

10

Fig. S8

HPLC Data for 4/5 Alkene/Alcohol Mixture

11

Fig. S9

LC-MS Data for 4/5 Alkene/Alcohol Mixture

12

Fig. S10

LC-MS Data for 4/5 Alkene/Alcohol Mixture (cont.)

13

Fig. S11

LC-MS Data for 4/5 Alkene/Alcohol Mixture (cont.)

14

Fig. S12

LC-MS Data for 4/5 Alkene/Alcohol Mixture (cont.)

15

Fig. S13

LC-MS Data for 4/5 Alkene/Alcohol Mixture (cont.)

16

Fig. S14

1

H NMR of D2O Exchange on 4/5 Mixture

17

Fig. S15

1

H NMR of D2O Exchange on 4/5 Mixture (cont.)

18

Fig. S16

1

H NMR of D2O Exchange on 4/5 Mixture (cont.)

19

Fig. S17

Discontinuous assay demonstrating C-S bond formation

20

Fig. S18

Discontinuous assay demonstrating C-S bond formation (cont.)

21

Fig. S19

Discontinuous assay demonstrating C-S bond formation (cont.)

22

Fig. S20

A) MS and B) MS-MS Fragmentation Analysis of bisubstrate 6

23

Fig. S21

Product-Based Transition-State Modeling (PBTSM) Expanded Descr.

24

H NMR spectrum of bromoacetyl PhAcGK 2b
C NMR spectrum of bromoacetyl PhAcGK 2b

5

9

S-‐1	
  
	
  

Table S1. PA4794 Mutagenesis Conditions.
Mutants were constructed using the conditions outlined below. All mutants were made using WT
DNA as template except R49QR141Q, which used R49Q DNA as template. Variations to the
procedure included adding 2% DMSO to the reaction for the R49A mutant and changing the
annealing temperature to 68°C for R49A, R141A, R141Q and 73°C for R49Q and R49QR141Q
mutants.
Original reagents and volumes from Phusion Site Directed Mutagenesis Protocol:
Component

50 µL Reaction

Final Concentration

Water

26 µL

-

5X Phusion HF Buffer

10 µL

1x

10 mM dNTPs

1 µL

200 µM

Forward Primer (10µM)

5 µL

1 µM

Reverse Primer (10µM)

5 µL

1 µM

Template DNA (10ng/µL)

2.5 µL

25 ng

Phusion Hot Start DNA Polymerase

0.5 µL

0.02 U/µL
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Table S2. Original Thermocycler conditions from Phusion Site Directed Mutagenesis Protocol:
Temperature (o C)

Time

Number of Cycles

Initial Denaturation

98

30 seconds

1

Denaturation

98

10 seconds

25

Anneal

70

30 seconds

25

Extension

72

5 minutes

25

Final Extension

72

7 minutes

1

“Hold”

4

∞

-
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Figure S1. Series of NPAcGK curves at varying concentrations of AcCoA. The fitting for the
kinetic model that was most compatible with the data, i.e. gave the best AICc value, is shown.
AICc values for each model are shown in the table beneath the figure. AcCoA concentrations
were 0.1, 0.25, 0.5, and 1mM for filled circles, open triangles, filled triangles, and open upside
down triangles, respectively. The most compatible model was the bireactant steady-state 3 model
as described in 1. A represents NPAcGK substrate and B is AcCoA.

Model

I : Bireactant Ordered A-First
II : Bireactant Ordered B-First
III : Bireactant Ping-Pong
IV : Bireactant Cooperative Ping-Pong
V : Bireactant Random Independent
VI : Bireactant Random Cooperative
VII : Bireactant Modified Hill
VIII : Bireactant Random Steady-State
IX : Bireactant Random Steady-State 2
X : Bireactant Random Steady-State 3

AICc Value

-214
-248
-309
-343
-270
-329
-335
-348
-350
-351
S-‐4	
  

	
  

Figure S2. 1H NMR for N6-(2-chloroacetyl)-N2-((2-phenylacetyl)glycyl)-L-lysine (2a)
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Figure S3. Homonuclear 1H-1H COSY NMR for N6-(2-chloroacetyl)-N2-((2phenylacetyl)glycyl)-L-lysine (2a)
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Figure S4. Mass Spectrum for N6-(2-chloroacetyl)-N2-((2-phenylacetyl)glycyl)-L-lysine (2a)
Spectrum Identification Results: + Scan (0.191-0.240 min) Sub (CTR-B-29. D (2a)
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Figure S5. 1H NMR for N6-(2-bromoacetyl)-N2-((2-phenylacetyl)glycyl)-L-lysine (2b)
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Figure S6.

13

C NMR for N6-(2-bromoacetyl)-N2-((2-phenylacetyl)glycyl)-L-lysine (2b)
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Figure S7. Homonuclear 1H-1H COSY NMR for N6-(2-bromoacetyl)-N2-((2phenylacetyl)glycyl)-L-lysine (2b)
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Figure S8. HPLC Data for 4/5 Alkene/Alcohol Mixture

HPLC Data
*DAD1 B, Sig=220,4 Ref=off (160613B\009-0101.D - 160613B\001-0201.D)
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min

Figure S9. LC-MS Data for 4/5 Alkene/Alcohol Mixture
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Peak

Figure S10. LC-MS Data for 4/5 Alkene/Alcohol Mixture
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Peak

Figure S11. LC-MS Data for 4/5 Alkene/Alcohol Mixture
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Figure S12. LC-MS Data for 4/5 Alkene/Alcohol Mixture
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Figure S13. LC-MS Data for 4/5 Alkene/Alcohol Mixture
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Figure S14. 1H NMR of D2O Exchange on 4/5 Mixture
1

H NMR:
7.5mg 4/5 in
750uL DMSO

	
  

1

H NMR:
7.5mg 4/5 in
750uL DMSO
+ 14uL D2O

	
  

	
  

S-‐17	
  
	
  

1

H NMR:
7.5mg 4/5 in
750uL DMSO
+ 30uL D2O

Figure S15. D2O Exchange on 4/5 Mixture
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Figure S16. D2O Exchange on 4/5 Mixture

COSY NMR:
7.5mg 4/5 in
750uL DMSO

	
  

S-‐19	
  
	
  

Figure S17. [A] Discontinuous assay demonstrating C-S bond formation. Assay result HPLC
Chromatogram for [B] Control: 4/5 Mix + Buffer. [C] Control: HSCoA + 4/5 Mix + Buffer. [D]
Trial 1: High conc. Enzyme + HSCoA + 4/5 Mix [E] Trial 2: Low conc. Enzyme + HSCoA + 4/5
Mix + Buffer. [F] Trial 3: HSCoA + 4/5 Mix + AIBN + Buffer.5
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Figure S18. [A] Discontinuous assay demonstrating C-S bond formation of bisubstrate 6.
[C]

[D]
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Figure S19. [A] Discontinuous assay demonstrating C-S bond formation producing
bisubstrate 6	
  
[E]

[F]
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Figure S20. A) MS and B) MS-MS Fragmentation Analysis of bisubstrate 6 produced by radical
addition to alkene, after Solid Phase Extraction (SPE) Preparation.
[A]

[B]
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Figure S21. Product-Based Transition-State Modeling (PBTSM) Expanded Description.
Protocol for systematic remodeling of tetrahedral intermediate and substrate binding modes from
product or bisubstrate bound crystal structures. Molecular minimization (MM) and molecular
dynamics (MD) stages in the protocol are shown. Further details are presented in Experimental
Procedures.	
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